MAPK1
Reaktivität: Human
WB, ELISA, IHC, IF
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
Western Blot (1:1000) Immunohistochemistry (1:50-100) The optimal working dilution should be determined by the end user.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Buffer
In PBS (0.09 % sodium azide)
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung
4 °C,-20 °C
Informationen zur Lagerung
Store at 4°C. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing.
Grey, Chen, Xu, Callon, Cornish et al.: "Parallel phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways subserve the mitogenic and antiapoptotic actions of insulin-like growth factor I in osteoblastic ..." in: Endocrinology, Vol. 144, Issue 11, pp. 4886-93, (2003) (PubMed).
Liao, Hung: "Regulation of the activity of p38 mitogen-activated protein kinase by Akt in cancer and adenoviral protein E1A-mediated sensitization to apoptosis." in: Molecular and cellular biology, Vol. 23, Issue 19, pp. 6836-48, (2003) (PubMed).
Sawafuji, Miyakawa, Kizaki, Ikeda: "Cyclosporin A induces erythroid differentiation of K562 cells through p38 MAPK and ERK pathways." in: American journal of hematology, Vol. 72, Issue 1, pp. 67-9, (2002) (PubMed).
Target
ERK2 (MAPK1)
(Mitogen-Activated Protein Kinase 1 (MAPK1))